The Board denied service connection for diabetes mellitus and its secondary effects on the Veteran's bilateral upper and lower extremities. The evidence did not show a link to service.,The Board also denied service connection for peripheral neuropathy of the right upper and lower extremities, as well as left upper and lower extremities, all secondary to diabetes mellitus. Again, there was no evidence linking these conditions to service.
The deciding factor: There is no probative evidence showing that the Veteran's diabetes mellitus or its related peripheral neuropathy were incurred in or caused by his active duty service.,The Board found insufficient evidence to establish a link between the Veteran's service and any of his claimed conditions, including diabetes mellitus and its secondary effects on his extremities.
- Claimed conditions
- diabetes mellitus, peripheral neuropathy, right upper extremity, peripheral neuropathy, right lower extremity, peripheral neuropathy, left upper extremity, peripheral neuropathy, left lower extremity
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- April 30, 2024
- Citation
- A24022120
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation A24022120.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Denied
The Board denied service connection for diabetes mellitus, prostate cancer, visual impairment, hypertension, and erectile dysfunction due to lack of exposure to herbicide agents during service. The Veteran's claims were not granted.
- Whole decision: Remanded (sent back)
The Veteran's claims for service connection on the merits are being remanded due to new evidence and development needs. The maximum disability rating for tinnitus has already been assigned.
- Whole decision: Denied
The Board denied service connection for diabetes mellitus, prostate cancer, ischemic heart disease, right lower extremity peripheral artery disease, left lower extremity peripheral artery disease, and hypertension as the evidence did not establish an in-service event or exposure to herbicide agents.
- Whole decision: Remanded (sent back)
The Board has granted the Veteran's requests to readjudicate his claims for service connection for coronary atherosclerosis and diabetes mellitus type II, but has remanded the cases due to new evidence received. The claims are being remanded for toxic exposure risk activity (TERA) medical opinions regarding any possible nexus between the Veteran's claimed exposures in Camp Lejeune and his conditions.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.